Access
To read this article in full you may need to log in, make a payment or gain access through a site license (see right).
Practice Point
Nature Reviews Gastroenterology and Hepatology 2, 72–73 (1 February 2005) | doi:10.1038/ncpgasthep0093
Risk of community-acquired pneumonia after acid-suppressive drugs
Abstract
Laheij RJF et al. (2004) Risk of community-acquired pneumonia and use of gastric acid-suppressive drugs. JAMA 292: 1955–1960 Synopsis Background The main treatments for gastroesophageal reflux disease and dyspepsia are proton pump inhibitors (PPIs) and H2-receptor antagonists (H2RAs).
To read this article in full you may need to log in, make a payment or gain access through a site license (see right).
